Cargando…
CXCL13 antibody for the treatment of autoimmune disorders
BACKGROUND: Homeostatic B Cell-Attracting chemokine 1 (BCA-1) otherwise known as CXCL13 is constitutively expressed in secondary lymphoid organs by follicular dendritic cells (FDC) and macrophages. It is the only known ligand for the CXCR5 receptor, which is expressed on mature B cells, follicular h...
Autores principales: | Klimatcheva, Ekaterina, Pandina, Tracy, Reilly, Christine, Torno, Sebold, Bussler, Holm, Scrivens, Maria, Jonason, Alan, Mallow, Crystal, Doherty, Michael, Paris, Mark, Smith, Ernest S, Zauderer, Maurice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329654/ https://www.ncbi.nlm.nih.gov/pubmed/25879435 http://dx.doi.org/10.1186/s12865-015-0068-1 |
Ejemplares similares
-
Generation and preclinical characterization of an antibody specific for SEMA4D
por: Fisher, Terrence L., et al.
Publicado: (2015) -
Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations
por: Evans, Elizabeth E, et al.
Publicado: (2015) -
Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity
por: Evans, Elizabeth E., et al.
Publicado: (2022) -
Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
por: Pan, Zijian, et al.
Publicado: (2022) -
Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D
por: Evans, Elizabeth E, et al.
Publicado: (2015)